Immunovant Inc (IMVT)

08:51 AM

Oppenheimer Maintains Outperform Rating on Immunovant (IMVT) Following Q2 2026 Earnings - MSN

08:51 AM

Nov 28, 2025

(IMVT) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com

Nov 28, 2025

Nov 28, 2025

12 Best Short Squeeze Stocks to Buy Right Now - Insider Monkey

Nov 28, 2025

Nov 26, 2025

Officer Geffner Files To Sell 50,000 Of Immunovant Inc [IMVT] - TradingView

Nov 26, 2025

Nov 25, 2025

Immunovant (IMVT): Assessing Valuation Following R&D Leadership Restructuring and CMO Departure - Sahm

Nov 25, 2025

Nov 24, 2025

JPMorgan Lowers PT on Immunovant (IMVT) to $33 From $37 - MSN

Nov 24, 2025

Nov 23, 2025

Have Insiders Sold Immunovant Shares Recently? - simplywall.st

Nov 23, 2025

Nov 22, 2025

Immunovant Restructures R&D Leadership with CMO Departure - The Globe and Mail

Nov 22, 2025

Nov 22, 2025

Immunovant COO Gloria sells $298k in shares By Investing.com - Investing.com Nigeria

Nov 22, 2025

Nov 21, 2025

Immunovant COO Gloria sells $298k in shares - Investing.com

Nov 21, 2025

Nov 21, 2025

Immunovant Insider Sold Shares Worth $298,237, According to a Recent SEC Filing - MarketScreener

Nov 21, 2025

Nov 21, 2025

Immunovant COO Gloria Melanie Sells Shares to Cover Tax Obligations - TradingView

Nov 21, 2025

Nov 21, 2025

[Form 4] Immunovant, Inc. Insider Trading Activity - Stock Titan

Nov 21, 2025

Nov 21, 2025

[8-K] Immunovant, Inc. Reports Material Event | IMVT SEC FilingForm 8-K - Stock Titan

Nov 21, 2025

Nov 21, 2025

Immunovant, Inc. Announces Cessation of Michael Geffner, M.D., M.B.A. as Chief Medical Officer, Effective November 21, 2025 - MarketScreener

Nov 21, 2025

Nov 19, 2025

How analysts rate Immunovant Inc. stock todayInsider Selling & Technical Entry and Exit Tips - newser.com

Nov 19, 2025

Nov 19, 2025

Will Immunovant Inc. stock outperform value stocksTrade Exit Summary & Weekly Breakout Watchlists - newser.com

Nov 19, 2025

Nov 19, 2025

Is Immunovant Inc. stock affected by interest rate hikesJuly 2025 Gainers & Stepwise Trade Signal Implementation - newser.com

Nov 19, 2025

Nov 18, 2025

Can swing trading help recover from Immunovant Inc. losses2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Nov 18, 2025

Nov 18, 2025

How Immunovant Inc. stock performs after earningsJuly 2025 Spike Watch & Community Consensus Trade Signals - newser.com

Nov 18, 2025

Nov 17, 2025

Responsive Playbooks and the IMVT Inflection - news.stocktradersdaily.com

Nov 17, 2025

Nov 16, 2025

Is Immunovant Inc. meeting your algorithmic filter criteriaPortfolio Value Summary & Safe Capital Growth Stock Tips - newser.com

Nov 16, 2025

Nov 16, 2025

Is Immunovant Inc. stock oversold or undervalued2025 Price Momentum & Weekly High Potential Alerts - newser.com

Nov 16, 2025

Nov 16, 2025

Key resistance and support levels for Immunovant Inc.Global Markets & Risk Adjusted Swing Trade Ideas - newser.com

Nov 16, 2025

Nov 16, 2025

Will Immunovant Inc. stock go up soonTrade Performance Summary & Free Low Drawdown Momentum Trade Ideas - newser.com

Nov 16, 2025

Nov 15, 2025

Sentiment analysis tools applied to Immunovant Inc.Weekly Stock Report & Low Risk High Win Rate Stock Picks - newser.com

Nov 15, 2025

Nov 15, 2025

Why Immunovant Inc. stock is popular among millennials2025 Technical Overview & Community Consensus Picks - newser.com

Nov 15, 2025

Nov 15, 2025

Why Immunovant Inc. stock is recommended by analystsWeekly Trade Analysis & Consistent Income Trade Ideas - newser.com

Nov 15, 2025

Nov 13, 2025

How institutional ownership impacts Immunovant Inc. stockMarket Activity Summary & Daily Profit Maximizing Trade Tips - newser.com

Nov 13, 2025

Nov 13, 2025

Immunovant, Inc. (NASDAQ:IMVT) Q2 2025 Earnings Call Transcript - Insider Monkey

Nov 13, 2025

Nov 12, 2025

Immunovant Inc Stock Analysis and ForecastStock Buyback Updates & Explosive Capital Growth Plans - earlytimes.in

Nov 12, 2025

Nov 12, 2025

Immunovant’s Earnings Call Highlights Clinical Success and Financial Strength - MSN

Nov 12, 2025

Nov 12, 2025

Immunovant's Q2 Loss Wider Than Expected, Pipeline in Focus - MSN

Nov 12, 2025

Nov 12, 2025

Immunovant stock rating reiterated by Oppenheimer, cites progress in autoimmune portfolio - Investing.com South Africa

Nov 12, 2025

Nov 11, 2025

Immunovant Bets Big On Autoimmune Drug Pipeline Progress - Finimize

Nov 11, 2025

Nov 11, 2025

Immunovant, Inc. (NASDAQ:IMVT) Q2 2026 Earnings Call Transcript - Insider Monkey

Nov 11, 2025